Company
MiNA Therapeutics
Activating RNA, mastering disease.
- Business model
- B2B
- Legal name
- MiNA Therapeutics Limited
Record updated 28 September 2026
About
MiNA Therapeutics is the global leader in small activating RNA therapeutics or RNAa. Harnessing innate mechanisms of gene activation, RNAa therapeutics are a revolutionary new class of medicines that can restore or boost normal function of genes and thereby protein-modulated pathways in cells. We are advancing a proprietary pipeline of new medicines with an initial focus on genetic medicine, while collaborating with leading pharmaceutical companies to apply our technology platform across a broad range of other therapeutic areas.
Products
- Web
- MTL-CEBPA
- Web
- MTL-HBG